Research Article| Volume 14, ISSUE 5, P559-561, May 1961

A new therapy for severe herpes simplex

      This paper is only available as a PDF. To read, Please Download here.


      The therapeutic effectiveness of Protamide was investigated in a series of twelve cases of severe herpes simplex seen in dental practice. Injections (1.3 ml.) were administered intramuscularly on two successive days. Excellent results were obtained in most patients and no side effects were seen. It appears that if the drug is going to be effective, relief should be obtained following the first two injections. Protamide is sufficiently effective to warrant its use in patients with severe herpes simplex. In the twelve cases studied, ten patients responded favorably and two showed no response.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Marsh W.C.
        Treatment of Herpes Zoster With Protamide.
        U. S. Armed Forces M. J. 1950; 1: 1045
        • Combes F.C.
        • Canizares O.
        Herpes Zoster: Its Treatment With Protamide.
        New York J. Med. 1952; 52: 706
        • Lehrer H.W.
        • Lehrer H.G.
        • Lehrer D.R.
        A New Treatment for Chickenpox and Other Virus Diseases: Preliminary Report.
        Ohio M. J. 1951; 47: 44
        • Lehrer H.W.
        • Lehrer H.G.
        • Lehrer D.R.
        Clinical Evaluation of Protamide in Sensory Nerve Root Inflammation and Allied Conditions.
        Northwest Med. 1955; 54: 1249
        • Smith R.T.
        Treatment of Neuritis With Protamide.
        New York Med. 1952; 8: 16
        • Lehman A.J.
        • Chase H.F.
        • Yonkman F.F.
        Pharmacologic Study of Protamide.
        Urol. & Cutan. Rev. 1944; 48: 378